Loss of SRY‐box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma

BACKGROUND: Oesophageal adenocarcinoma (OAC) is a highly aggressive malignancy with poor survival, which is highly variable amongst patients with comparable conventional prognosticators. Therefore molecular biomarkers are urgently needed to improve the prediction of survival in these patients. SRY (...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Br J Surg
Autori principali: ten Kate, F. J. C., van Olphen, S. H., Bruno, M. J., Wijnhoven, B. P. L., van Lanschot, J. J. B., Looijenga, L. H. J., Fitzgerald, R. C., Biermann, K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Ltd 2017
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5600089/
https://ncbi.nlm.nih.gov/pubmed/28692180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bjs.10553
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi